PARN and dyskeratosis congenita: Due to an identified presence of compound heterozygosity in PARN and further functional assays, the patient was classified as having dyskeratosis congenita.21 Analysis of the NGS reads by NextGene revealed both the heterozygous deletion and pathogenic point variant.